| 臺大學術典藏 |
2020-03-27T05:28:38Z |
Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia
|
Jean S.-S.;Ou T.-Y.;Chen F.-L.;Hsieh T.-C.;PO-REN HSUEH;Lee W.-S.; Lee W.-S.; PO-REN HSUEH; Hsieh T.-C.; Chen F.-L.; Ou T.-Y.; Jean S.-S. |
| 臺大學術典藏 |
2020-03-27T05:28:35Z |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
PO-REN HSUEH;Wang F.-D.;Ko W.-C.;Shao P.-L.;Lu P.-L.;Wu T.-S.;Tseng S.-H.;Shi Z.-Y.;Lu M.-C.;Jean S.-S.; Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; Shao P.-L.; Ko W.-C.; Wang F.-D.; PO-REN HSUEH |
| 臺大學術典藏 |
2020-03-27T05:28:34Z |
Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the enterobacteriaceae isolates causing intra-abdominal infections in the asia-pacific region: Results from the study for monitoring antimicrobial resistance trends (SMART)
|
SMART Asia-Pacific Group;PO-REN HSUEH;Lee W.-S.;Jean S.-S.; Jean S.-S.; Lee W.-S.; PO-REN HSUEH; SMART Asia-Pacific Group |
| 臺大學術典藏 |
2020-03-27T05:28:33Z |
Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976] (S1684118215000213) (10.1016/j.jmii.2014.12.008))
|
PO-REN HSUEH; Liu C.-Y.; Lam C.; Lu M.-C.; Liu J.-W.; Chen Y.-S.; PO-REN HSUEH;Liu C.-Y.;Lam C.;Lu M.-C.;Liu J.-W.;Chen Y.-S.;Chen Y.-H.;Wu J.-J.;Chen R.-J.;Ko W.-C.;Chang F.-Y.;Hsu C.-W.;Liao C.-H.;Yu K.-W.;Lee W.-S.;Jean S.-S.; Jean S.-S.; Lee W.-S.; Yu K.-W.; Liao C.-H.; Hsu C.-W.; Chang F.-Y.; Ko W.-C.; Chen R.-J.; Wu J.-J.; Chen Y.-H. |
| 臺大學術典藏 |
2020-03-27T05:28:30Z |
Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
|
Lam C.;Hsu C.-W.;PO-REN HSUEH;Lee W.-S.;Hsieh T.-C.;Jean S.-S.; Jean S.-S.; Hsieh T.-C.; Lee W.-S.; PO-REN HSUEH; Hsu C.-W.; Lam C. |
| 臺大學術典藏 |
2020-03-27T05:28:29Z |
Carbapenem-resistant enterobacteriaceae infections: Taiwan aspects
|
PO-REN HSUEH; Ko W.-C.; Lu M.-C.; Tang H.-J.; Lee N.-Y.; Jean S.-S.; PO-REN HSUEH;Ko W.-C.;Lu M.-C.;Tang H.-J.;Lee N.-Y.;Jean S.-S. |
| 臺大學術典藏 |
2020-03-27T05:28:24Z |
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
|
International Society of Antimicrobial Chemotherapy (ISAC);PO-REN HSUEH;Lee W.-S.;Gould I.M.;Jean S.-S.; Jean S.-S.; Gould I.M.; Lee W.-S.; PO-REN HSUEH; International Society of Antimicrobial Chemotherapy (ISAC) |
| 臺大學術典藏 |
2020-03-27T05:28:24Z |
Corrigendum to “Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia” (Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia (2017) 50(4) (547–548), (S1684118216300299), (10.1016/j.jmii.2016.03.008))
|
Jean S.-S.;Ou T.-Y.;Chen F.-L.;Hsieh T.-C.;PO-REN HSUEH;Lee W.-S.; Lee W.-S.; PO-REN HSUEH; Hsieh T.-C.; Chen F.-L.; Ou T.-Y.; Jean S.-S. |
| 臺大學術典藏 |
2020-03-27T05:28:23Z |
Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci
|
PO-REN HSUEH;Hwang J.-J.;Hsueh S.-C.;Jean S.-S.; Jean S.-S.; Hsueh S.-C.; Hwang J.-J.; PO-REN HSUEH |
| 臺大學術典藏 |
2020 |
Treatment options for COVID-19: The reality and challenges
|
PO-REN HSUEH; Jean S.-S.;Lee P.-I.;Po-Ren Hsueh; Jean S.-S.; Lee P.-I. |
| 臺大學術典藏 |
2020 |
Lemierre's syndrome: A forgotten and re-emerging infection
|
Lee W.-S.; Jean S.-S.; Chen F.-L.; SZU-MIN HSIEH; Hsueh P.-R. |
| 國立成功大學 |
2020 |
Extra-respiratory manifestations of COVID-19
|
Lai, C.-C.;Ko, W.-C.;Lee, P.-I.;Jean, S.-S.;Hsueh, P.-R. |
| 國立成功大學 |
2020 |
Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (AT
|
Jean, S.-S.;Ko, W.-C.;Hsueh, P.-R.;Group, SMART Study |
| 臺大學術典藏 |
2019-12-04T08:44:24Z |
Acute generalized exanthematous pustulosis due to teicoplanin [3]
|
Chia-Yu Chu;Wu J.;Jean S.-S.;Sun C.-C.; CHIA-YU CHU; Wu J.; Jean S.-S.; Sun C.-C. |
| 臺大學術典藏 |
2019 |
Breakthrough invasive Trichosporon asahii infection in an uremic patient with systemic calciphylaxis complicating necrotizing fasciitis during echinocandin therapy for C. tropicalis
|
Lee W.-S.;Chen F.-L.;Jean S.-S.;PO-REN HSUEH;Wang C.-H.;Tsai Y.-H.; Tsai Y.-H.; Wang C.-H.; PO-REN HSUEH; Jean S.-S.; Chen F.-L.; Lee W.-S. |
| 臺大學術典藏 |
2019 |
Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
|
PO-REN HSUEH; Lee W.-S.; Hsueh S.-C.; Jean S.-S.; PO-REN HSUEH;Lee W.-S.;Hsueh S.-C.;Jean S.-S. |
| 臺大學術典藏 |
2019 |
Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci
|
Jean S.-S.;Hsueh S.-C.;Hwang J.-J.;Po-Ren Hsueh; Jean S.-S.; Hsueh S.-C.; Hwang J.-J.; PO-REN HSUEH |
| 臺大學術典藏 |
2019 |
Corrigendum to “Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia” (Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia (2017) 50(4) (547–548), (S1684118216300299), (10.1016/j.jmii.2016.03.008))
|
Lee W.-S.;Po-Ren Hsueh;Hsieh T.-C.;Chen F.-L.;Ou T.-Y.;Jean S.-S.; Lee W.-S.; PO-REN HSUEH; Hsieh T.-C.; Chen F.-L.; Ou T.-Y.; Jean S.-S. |
| 臺大學術典藏 |
2019 |
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
|
Jean S.-S.;Gould I.M.;Lee W.-S.;Po-Ren Hsueh;International Society Of Antimicrobial Chemotherapy (Isac); Jean S.-S.; Gould I.M.; Lee W.-S.; PO-REN HSUEH; International Society of Antimicrobial Chemotherapy (ISAC) |
| 臺大學術典藏 |
2018 |
Corrigendum to “Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam” [J Microbiol Immunol Infect (2017) 50: 454–463](S1684118215008476)(10.1016/j.jmii.2015.08.024)
|
PO-REN HSUEH;Lee W.-S.;Sheng W.-H.;Liao C.-H.;Jean S.-S.; Jean S.-S.; Liao C.-H.; Sheng W.-H.; Lee W.-S.; PO-REN HSUEH |
| 臺大學術典藏 |
2018 |
Carbapenem-resistant enterobacteriaceae infections: Taiwan aspects
|
Jean S.-S.;Lee N.-Y.;Tang H.-J.;Lu M.-C.;Ko W.-C.;Po-Ren Hsueh; Jean S.-S.; Lee N.-Y.; Tang H.-J.; Lu M.-C.; Ko W.-C.; PO-REN HSUEH |
| 臺大學術典藏 |
2018 |
Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the enterobacteriaceae isolates causing intra-abdominal infections in the asia-pacific region: Results from the study for monitoring antimicrobial resistance trends (SMART)
|
Jean S.-S.;Lee W.-S.;Po-Ren Hsueh;Smart Asia-Pacific Group; Jean S.-S.; Lee W.-S.; PO-REN HSUEH; SMART Asia-Pacific Group |
| 臺大學術典藏 |
2018 |
Corrigendum to “Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam” [J Microbiol Immunol Infect (2017) 50: 454–463](S1684118215008476)(10.1016/j.jmii.2015.08.024)
|
PO-REN HSUEH; Lee W.-S.; Sheng W.-H.; Liao C.-H.; Jean S.-S.; Jean S.-S.;Liao C.-H.;Sheng W.-H.;Lee W.-S.;Po-Ren Hsueh |
| 國立成功大學 |
2018 |
Carbapenem-resistant enterobacteriaceae infections: Taiwan aspects
|
Jean, S.-S.;Lee, N.-Y.;Tang, H.-J.;Lu, M.-C.;Ko, W.-C.;Hsueh, P.-R. |
| 國立成功大學 |
2018 |
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART)
|
Jean, S.-S.;Lu, M.-C.;Shi, Z.-Y.;Tseng, S.-H.;Wu, T.-S.;Lu, P.-L.;Shao, P.-L.;Ko, W.-C.;Wang, F.-D.;Hsueh, P.-R. |
